Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2026-01-02 | Reverse | 1:30 |
| 2023-12-07 | Reverse | 1:15 |
PAVmed Inc. is a U.S.-based medical device company developing innovative products for diagnostics, minimally invasive treatments, and healthcare monitoring across various medical fields.

EsoGuard is a non-invasive test that analyzes esophageal DNA via the EsoCheck device to detect early esophageal precancer and cancer, with recent U.S. VA contract boosting its market presence.
| Icon | PRODUCT | Q3-2022 | Q4-2022 | Q1-2023 | Q2-2023 |
|---|---|---|---|---|---|
![]() | Royalty | $4K | $0 ▼ | $24K ▲ | $10K ▼ |
Overall rating: C
| PEER | PRICE | |
|---|---|---|
ADVB | $8.14 | COMPARE |
BNR | $9.78 | COMPARE |
HSCS | $2.80 | COMPARE |
BMRA | $1.61 | COMPARE |
TNON | $6.83 | COMPARE |
APVO | $2.68 | COMPARE |
SSKN | $0.00 | COMPARE |